K. Sun et al., DIFFERENTIAL EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1 AND TYPE-2 IN HUMAN PLACENTA AND FETAL MEMBRANES, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 300-305
Two isoforms of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) are
present in mammals. 11 beta HSD1 interconverts biologically active co
rtisol and inactive cortisone, whereas 11 beta HSD2 only converts cort
isol to cortisone. Placental 11 beta HSD has been proposed to protect
the fetus from high level of maternal glucocorticoids. Although bidire
ctional activity of 11 beta HSD has been demonstrated in homogenized h
uman placental tissues, the tissue and cellular distribution of 11 bet
a HSD1 has not been resolved. In this study, the cellular localization
of 11 beta HSD1 protein and levels of its messenger ribonucleic acid
(mRNA) in human placenta and fetal membranes were determined by immuno
histochemistry and Northern blot analysis, respectively. We found that
11 beta HSD1 immunoreactivity was present in the placental extravillo
us intermediated trophoblasts, chorion trophoblasts, amnion epithelial
cells, and stromal cells of the decidua vera. Positive staining was a
lso observed in the endothelium of the blood vessels in both placental
villous tissue and umbilical cord. However, in contrast to previous r
eports of immunoreactive 11 beta HSD2 localization, 11 beta HSD1 immun
oreactivity was undetectable in placental syncytiotrophoblast. Using a
human 11 beta HSD1 complementary DNA as probe, a 1.5-kilobase mRNA tr
anscript was detected in the chorion, amnion, and placental tissue, wi
th the greatest amount in the chorion. In contrast, the 1.9-kilobase m
RNA of 11 beta HSD2 was observed only in the placenta, not in the chor
ion and amnion. The process of labor had no significant effect on leve
ls of 11 beta HSD1 or 11 beta HSD2 mRNA in the chorion or placenta. We
conclude that there is a striking difference in the tissue localizati
on of 11 beta HSD1 and 11 beta HSD2 expression in the late gestation h
uman placenta and fetal membranes, which may discretely determine the
accessibility of bioactive glucocorticoid to specific cell types.